Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Azafaros B.V.
Sponsor

Azafaros B.V.

The Netherlands J.H. Oortweg 21, 2333 CH Leiden, The Netherlands

About the sponsor

Azafaros B.V. focuses on rare inherited disorders involving abnormal glycosphingolipid accumulation, with research centred on conditions that affect the nervous system and other organs.

  • Niemann-Pick type C disease
  • GM1 gangliosidosis
  • GM2 gangliosidosis

The sponsor’s clinical activity is directed toward neurologic manifestations associated with these diseases, including movement impairment and progressive functional decline.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Study on the Effectiveness and Safety of Nizubaglustat in Patients with Niemann-Pick Type C, GM1, or GM2 Gangliosidosis

Recruiting
Investigational
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years
  • Substances:NIZUBAGLUSTAT
  • Sponsor:Azafaros B.V.

A study to evaluate how the body processes AZ-3102 in healthy male subjects

Not recruiting
InvestigationalNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:(2S,3R,4R,5S)-1-[5-(2-FLUORO-BIPHENYL-4-YLMETHOXY)-PENTYL]-2-HYDROXYMETHYL-PIPERIDINE-3,4,5-TRIOL
  • Sponsor:Azafaros B.V.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.